Bacterial Capsular Polysaccharides and Exopolysaccharides

Microbial Glycobiology

Volumn , Issue , 2010, Pages 93-108

  Cescutti, Paola ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953846720     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374546-0.00006-7     Document Type: Chapter

References (53)

1. Bebault G.M., Dutton G.G.S., Funnell N.A., Mackie K.L. Structural investigation of Klebsiella serotype K32 polysaccharide. Carbohydr. Res. 1978, 63:183-192.
2. Burkholder W.H. Sour skin, a bacterial rot of onion bulbs. Phytopathology 1950, 40:115-117.
3. Bylund J., Burgess L.A., Cescutti P., Ernst R.K., Speert D.P. Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species. J. Biol. Chem. 2006, 281:2526-2532.
4. Cérantola S., Marty N., Montrozier H. Structural studies of the acidic exopolysaccharide produced by a mucoid strain of Burkholderia cepacia, isolated from cystic fibrosis. Carbohydr. Res. 1996, 285:59-67.
5. Cérantola S., Lemassu-Jacquier A., Montrozier H. Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit. Eur. J. Biochem. 1999, 260:373-383.
6. Cescutti P., Toffanin R., Kvam B.J, Paoletti S., Dutton G.G.S. Structural determination of the capsular polysaccharide produced by Klebsiella pneumoniae serotype K40. NMR studies of the oligosaccharide obtained upon depolymerisation of the polysaccharide with a bacteriophage-associated endoglycanase. Eur. J. Biochem. 1993, 213:445-453.
7. Cescutti P., Impallomeni G., Garozzo D., et al. Novel exopolysaccharides produced by a clinical strain of Burkholderia cepacia isolated from a cystic fibrosis patient. Carbohydr. Res. 2003, 338:2687-2695.
8. Cescutti P., Scussolin S., Herasimenka Y., Impallomeni G., Bicego M., Rizzo R. First report of a lyase for cepacian, the polysaccharide produced by Burkholderia cepacia complex bacteria. Biochem. Biophys. Res. Commun. 2006, 339:821-826.
9. Chandrasekaran R., Thailambal V.G. The influence of calcium ions, acetate and l-glycerate groups on the gellan double-helix. Carbohydr. Polym. 1990, 12:431-442.
10. Conway B.D., Chu K.K., Bylund J., Altman E., Speert D.P. Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. J. Infect. Dis. 2004, 190:957-966.
11. Costerton J.W., Irwin R.T., Cheng K.-J. The bacterial glycocalix in nature and disease. Annu. Rev. Microbiol. 1981, 35:299-324.
12. De Philippis R., Vincenzini M. Exocellular polysaccharides from cyanobacteria and their possible applications. FEMS Microbiol. Rev. 1998, 22:151-175.
13. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15:167-193.
14. Dutton G.G.S. Capsular polysaccharides of Gram negative bacteria. New Developments in Industrial Polysaccharides 1984, 7-26. Gordon and Breach Science Publishers, Amsterdam. V. Crescenzi, I.C.M. Dea, S.S. Stivala (Eds.).
15. Dutton G.G.S., Di Fabio J. The capsular polysaccharide of Klebsiella serotype K60; a novel structural pattern. Carbohydr. Res. 1980, 87:129-139.
16. Gacesa P., Russell N.J. Pseudomonas Infection and Alginates: Biochemistry, Genetics and Pathology 1990, Chapman and Hall, London.
17. Garegg P.J., Jansson P.-E., Lindberg B., et al. Configuration of the acetal carbon atom of pyruvic acid acetals in some bacterial polysaccharides. Carbohydr. Res. 1980, 78:127-132.
18. Govan J.R.W., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 1996, 60:539-574.
19. Griffiths A.J., Davies D.B. Type specific carbohydrate antigens of pathogenic bacteria. Part 1: Enterobacteriaceae. Carbohydr. Polym. 1991, 14:241-279.
20. Griffiths A.J., Davies D.B. Type specific carbohydrate antigens of pathogenic bacteria. Part 2. Carbohydr. Polym. 1991, 14:339-365.
21. Herasimenka Y., Benincasa M., Mattiuzzo M., Cescutti P., Gennaro R., Rizzo R. Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 2005, 26:1127-1132.
22. Herasimenka Y., Cescutti P., Sampaio Noguera C.E., et al. Macromolecular properties of cepacian in water and in dimethylsulfoxide. Carbohydr. Res. 2008, 343:81-89.
23. Jackson G.E., Ravenscroft N., Stephen A.M. The use of bacteriophage-mediated depolymerisation in investigations of the structure of the capsular polysaccharide from Klebsiella serotype K71. Carbohydr. Res. 1990, 200:409-428.
24. Jann B., Jann K. Structure and biosynthesis of the capsular antigens of Escherichia coli. Curr. Top. Microbiol. 1990, 150:19-42.
25. Kenne L., Lindberg B. Bacterial polysaccharides. The Polysaccharides 1983, Vol. 2:287-363. Academic Press Inc, New York. G. Aspinall (Ed.).
26. Kumar A.S., Mody K., Jha B. Bacterial exopolysaccharides - a perception. J. Basic Microb. 2007, 47:103-117.
27. Lacaze G., Wick M., Cappelle S. Emerging fermentation technologies: development of novel sourdoughs. Food Microbiol. 2007, 24:155-160.
28. Learn D.B., Brestel E.P., Seetharama S. Hypochlorite scavenging by Pseudomonas aeruginosa alginate. Infect. Immun. 1987, 55:1813-1818.
29. Lindberg B. Components of bacterial polysaccharides. Adv. Carbohydr. Chem. Biochem. 1990, 48:279-318.
30. Llull D., López R., García E. Genetic bases and medical relevance of capsular polysaccharide biosynthesis in pathogenic streptococci. Curr. Mol. Med. 2001, 1:475-491.
31. Mancuso Nichols C.A., Guezennec J., Bowman J.P. Bacterial exopolysaccharides from extreme marine environments with special consideration on the Southern ocean, sea ice, and deep-sea hydrothermal vents: a review. Mar. Biotechnol. 2005, 7:253-271.
32. Mathee K., Ciofu O., Sternberg C., et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 1999, 145:1349-1357.
33. Michalek M.T., Mold C., Bremer E.G. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid. J. Immunol. 1988, 140:1588-1594.
34. Morris E.R., Rees D.A., Thom D., Boyd J. Chiroptical and stoichiometric evidence of a specific, primary dimerisation process in alginate gelation. Carbohydr. Res. 1978, 66:145-154.
35. Nigou J., Gilleron M., Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie 2003, 85:153-166.
36. O'Riordan K., Lee J.C. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 2004, 17:218-234.
37. Ovodov Y.S. Bacterial capsular antigens. Structural patterns of capsular antigens. Biochemistry (Moscow) 2006, 71:937-954.
38. Pier G.B., Coleman F., Grout M., Franklin M., Ohman D.E. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect. Immun. 2001, 69:1895-1901.
39. Raffatellu M., Chessa D., Wilson R.P., Tükel Ç., Akçelik M., Bäumler A.J. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect. Immun. 2006, 74:19-27.
40. Rao V.S.R., Qasba P.K., Balaji P.V., Chandrasekaran R. Conformation of Carbohydrates 1998, Harwood Academic Publishers, Amsterdam.
41. Remminghorst U., Rehm B.H.A. Bacterial alginates: from biosynthesis to applications. Biotechnol. Lett. 2006, 28:1701-1712.
42. Sage A., Linker A., Evans L.R., Lessie T.G. Hexose phosphate metabolism and exopolysaccharide formation in Pseudomonas cepacia. Curr. Microbiol. 1990, 20:191-198.
43. Sampaio Nogueira C.E., Ruggiero J.R., Sist P., Cescutti P., Urbani R., Rizzo R. Conformational features of cepacian: the exopolysaccharides produced by clinical strains of Burkholderia cepacia. Carbohydr. Res. 2005, 340:1025-1037.
44. Simpson J.A., Smith S.E., Dean R.T. Scavenging by alginate of free radicals released by macrophages. Free Radical Bio. Med. 1989, 6:347-353.
45. Sutherland I.W. Structure-function relationships in microbial exopolysaccharides. Biotechnol. Adv. 1994, 12:393-448.
46. Sutherland I.W. Microbial polysaccharide products. Biotechnol. Genet. Eng. 1999, 16:217-229.
47. Taylor C.M., Roberts I.S. Capsular polysaccharides and their role in virulence. Contrib. Microbiol. 2005, 12:55-66.
48. van Dam J.E.G., Fleer A., Snippe H. Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie van Leeuwenhoek 1990, 58:1-47.
49. Weintraub A. Immunology of bacterial polysaccharide antigens. Carbohydr. Res. 2003, 338:2539-2547.
50. Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 2006, 75:39-68.
51. Widner B., Behr R., Von Dollen S., et al. Hyaluronic acid production in Bacillus subtilis. Appl. Environ. Microb. 2005, 71:3747-3752.
52. Zevenhuizen L.P.T.M. Succinoglycan and galactoglucan. Carbohydr. Polym. 1997, 33:139-144.
53. Zlosnik J.E., Hird T.J., Fraenkel M.C., Moreira L.M., Henry D.A., Speert D.P. Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J. Clin. Microbiol. 2008, 46:1470-1473.